SHORTEST AND PRECISE REVIEW OF LITERATURE ON CLOBAZAM ROLE IN FEBRILE SEIZURES
Size: 47.03 KB
Language: en
Added: Aug 28, 2018
Slides: 3 pages
Slide Content
CLOBAZAM in FEBRILE SEIZURE PROPHYLAXIS DR SHAILESH MEHTA MD PEDIATRICS
EVIDENCE BASED FACTS Cochrane meta- analysis and ILAE don’t support use of CLOBAZAM in febrile seizures. Cochrane Database of Systematic Reviews 2017, Issue 2. Art. No.: CD003031 . included 40 articles describing 30 randomised trials with 4256 randomised participants RESULT: CLOBAZAM INEFFECTIVE Most studies in favour have sample size 25-70 patients only Indian J Pediatr (2011) 78:38–40 Manreza et al,Arq Neuropsiquiatr 1997;55(4) Rose et al, Indian J Pediatr 2005;72(1)
RESCUE VS PROPHYLAXIS RESCUE- IF SEIZURE MORE THAN 15 MIN DIAZEPAMI.V./ RECTAL-0.3- 0.5MG /KG/DOSE MIDAZOLAM INTRANASAL-0.2MG/KG/DOSE CLOBAZAM- NOT USED Cochrane Database of Systematic Reviews 2017, Issue 2. Art. No.: CD003031 Lancet 2005,;366:205-10 PROPHYLAXIS - NO MORE USED- PHENOBARB, VALPARIN DIAZEPAM(ORAL) – 0.3 MG/KG/DOSE 12 HOURLY TILL AFEBRILE FOR 24 HRS CLOBAZAM(ORAL)- 0.5 MG/KG/DOSE- 12HOURLY- FOR 48HRS RANGE 0.3-1MG/KG/DOSE